← All trials
NCT04388982
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 25, 2020
- Primary completion
- Apr 30, 2021
- Completion date
- Apr 30, 2022
- First posted
- May 15, 2020
- Last posted
- May 15, 2020
- Enrollment
- 9
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Jiao Tong UniversityLead sponsor
- Jiao Tong UniversityOverall official - principal investigator
- Jiao Tong UniversityOverall official - principal investigator
- Cellular Biomedicine Group Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.